Reconciling Sentinel Node Omission with CDK4/6 Inhibitor Eligibility in HR+/HER2- Early Breast Cancer: A Real-World Cohort Analysis
Author:
Jannik Daniel Kandzi,Alexander Englisch,Bettina Boeer,Markus Hahn,Markus Wallwiener,Léa Volmer,Sara Brucker,Andreas Hartkopf,Tobias Engler
Publication:
Clinical Breast Cancer
© 2025 The Authors. Published by Elsevier Inc.